Cerevel Therapeutics Holdings, Inc. (CERE) NASDAQ
$44.96 0.33 (0.74%)
Market Cap: $8.19B
As of 07/31/24 04:00 PM EDT. Market closed.
Cerevel Therapeutics Holdings, Inc. (CERE)
NASDAQ
$44.96
0.33 (0.74%)
Market Cap: $8.19B
As of 07/31/24 04:00 PM EDT. Market closed.
Add to Portfolio
Cerevel Therapeutics Holdings, Inc., founded in 2018 in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company developing therapies for neuroscience diseases. Their extensive pipeline includes Phase 3 trials for tavapadon in Parkinson’s, Phase 2 trials for emraclidine in schizophrenia, and Phase 2 trials for darigabat in epilepsy and panic disorder. Utilizing targeted ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Ronald C. Renaud Jr., M.B.A.
Full Time Employees
355
CEO Compensation (Base)
$642,735
CEO Compensation (Total)
$11.23M
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Ronald C. Renaud Jr., M.B.A.
Full Time Employees
355
CEO Compensation (Base)
$642,735
CEO Compensation (Total)
$11.23M
URL
Address
222 Jacobs Street, Suite 200, MA, Cambridge, 02141.
PRICE CHART FOR CEREVEL THERAPEUTICS HOLDINGS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$44.98
Previous Close
$44.63
Days Range
$44.96 - $44.99
52 week range
$19.59 - $44.99
Volume
15,033,754
Avg. Volume (30 days)
2,056,487
Market Cap
$8.19B
Dividend Yield
-
P/E
(16.47)
Shares Outstanding
182,195,008
Open
$44.98
Previous Close
$44.63
Days Range
$44.96 - $44.99
52 week range
$19.59 - $44.99
Volume
15,033,754
Avg. Volume (30 days)
2,056,487
Market Cap
$8.19B
Dividend Yield
-
P/E
(16.47)
Shares Outstanding
182,195,008
FINANCIAL STATEMENTS FOR CEREVEL THERAPEUTICS HOLDINGS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CEREVEL THERAPEUTICS HOLDINGS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| PFIZER INC | Former 10% Owner | Aug 01, 2024 | Option Exercise | $45.00 | 27,349,211 | 1,230,714,495 | 0 | Aug 05, 2024, 06:25 PM |
| COLES N ANTHONY | Director | Jul 01, 2024 | Option Exercise | $3.50 | 25,000 | 87,500 | 50,928 | Jul 03, 2024, 04:05 PM |
| COLES N ANTHONY | Director | Jul 01, 2024 | Sale | $41.18 | 25,000 | 1,029,535 | 25,928 | Jul 03, 2024, 04:05 PM |
| COLES N ANTHONY | Director | Jun 03, 2024 | Option Exercise | $3.50 | 50,000 | 175,000 | 65,638 | Jun 05, 2024, 04:05 PM |
| COLES N ANTHONY | Director | Jun 03, 2024 | Sale | $40.61 | 50,000 | 2,030,520 | 15,638 | Jun 05, 2024, 04:05 PM |
| COLES N ANTHONY | Director | May 10, 2024 | Option Exercise | $3.50 | 50,000 | 175,000 | 65,638 | May 14, 2024, 05:16 PM |
| COLES N ANTHONY | Director | May 10, 2024 | Sale | $42.10 | 50,000 | 2,105,125 | 15,638 | May 14, 2024, 05:16 PM |
| COLES N ANTHONY | Director | Apr 01, 2024 | Option Exercise | $3.50 | 50,000 | 175,000 | 65,638 | Apr 03, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Apr 01, 2024 | Sale | $42.33 | 50,000 | 2,116,640 | 15,638 | Apr 03, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Mar 04, 2024 | Option Exercise | $3.50 | 50,000 | 175,000 | 65,638 | Mar 06, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Mar 04, 2024 | Sale | $41.01 | 50,000 | 2,050,550 | 15,638 | Mar 06, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Feb 29, 2024 | Option Exercise | $3.50 | 50,000 | 175,000 | 65,638 | Mar 04, 2024, 05:49 PM |
| COLES N ANTHONY | Director | Feb 29, 2024 | Sale | $41.16 | 50,000 | 2,057,890 | 15,638 | Mar 04, 2024, 05:49 PM |
| Renger John | Chief Scientific Officer | Feb 07, 2024 | Sale | $41.54 | 2,161 | 89,777 | 6,370 | Feb 08, 2024, 07:19 PM |
| COLES N ANTHONY | Director | Feb 07, 2024 | Sale | $41.54 | 2,506 | 104,110 | 15,638 | Feb 08, 2024, 07:14 PM |
| Tregoning Kathleen | See Remarks | Dec 26, 2023 | Option Exercise | $10.05 | 3,150 | 31,658 | 10,666 | Dec 28, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 26, 2023 | Option Exercise | $3.50 | 10,000 | 35,000 | 24,673 | Dec 28, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 26, 2023 | Sale | $42.47 | 10,000 | 424,700 | 14,673 | Dec 28, 2023, 04:15 PM |
| DiPietro Kenneth | Chief Human Resources Officer | Dec 22, 2023 | Option Exercise | $3.50 | 8,000 | 28,000 | 32,663 | Dec 27, 2023, 04:15 PM |
| DiPietro Kenneth | Chief Human Resources Officer | Dec 22, 2023 | Sale | $41.45 | 8,000 | 331,608 | 24,663 | Dec 27, 2023, 04:15 PM |
| Bodenrader Mark | See Remarks | Dec 20, 2023 | Sale | $41.42 | 7,889 | 326,788 | 17,724 | Dec 21, 2023, 08:27 PM |
| DiPietro Kenneth | Chief Human Resources Officer | Dec 20, 2023 | Sale | $41.42 | 6,256 | 259,144 | 24,663 | Dec 21, 2023, 08:24 PM |
| Akamine Scott | Chief Legal Officer | Dec 20, 2023 | Sale | $41.42 | 7,072 | 292,945 | 7,237 | Dec 21, 2023, 08:21 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 20, 2023 | Sale | $41.42 | 10,152 | 420,528 | 14,673 | Dec 21, 2023, 08:14 PM |
| ALTSCHULLER Susan | Chief Financial Officer | Dec 20, 2023 | Sale | $41.42 | 13,808 | 571,972 | 16,913 | Dec 21, 2023, 08:12 PM |
| Tregoning Kathleen | See Remarks | Dec 20, 2023 | Sale | $41.42 | 6,288 | 260,469 | 7,516 | Dec 21, 2023, 08:10 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 15, 2023 | Option Exercise | $9.88 | 7,500 | 74,100 | 7,500 | Dec 19, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 15, 2023 | Sale | $41.39 | 7,500 | 310,393 | 0 | Dec 19, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 07, 2023 | Option Exercise | $3.50 | 10,000 | 35,000 | 10,000 | Dec 11, 2023, 04:17 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 07, 2023 | Sale | $41.37 | 10,000 | 413,700 | 0 | Dec 11, 2023, 04:17 PM |
| Akamine Scott | Chief Legal Officer | Dec 07, 2023 | Option Exercise | $13.17 | 10,000 | 131,700 | 10,513 | Dec 07, 2023, 07:45 PM |
| Akamine Scott | Chief Legal Officer | Dec 05, 2023 | Option Exercise | $13.17 | 7,500 | 98,775 | 8,013 | Dec 07, 2023, 07:45 PM |
| Akamine Scott | Chief Legal Officer | Dec 07, 2023 | Sale | $41.37 | 10,000 | 413,700 | 513 | Dec 07, 2023, 07:45 PM |
| Akamine Scott | Chief Legal Officer | Dec 05, 2023 | Sale | $35.00 | 7,500 | 262,500 | 513 | Dec 07, 2023, 07:45 PM |
| COLES N ANTHONY | Director | Nov 14, 2023 | Option Exercise | $3.50 | 22,824 | 79,884 | 25,528 | Nov 16, 2023, 04:15 PM |
| COLES N ANTHONY | Director | Nov 14, 2023 | Sale | $25.13 | 22,824 | 573,455 | 2,704 | Nov 16, 2023, 04:15 PM |
| COLES N ANTHONY | Director | Nov 08, 2023 | Option Exercise | $3.50 | 100 | 350 | 2,804 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 07, 2023 | Option Exercise | $3.50 | 27,076 | 94,766 | 29,780 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 08, 2023 | Sale | $25.16 | 100 | 2,516 | 2,704 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 07, 2023 | Sale | $25.02 | 27,076 | 677,555 | 2,704 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 03, 2023 | Option Exercise | $3.50 | 61,401 | 214,904 | 64,105 | Nov 06, 2023, 05:12 PM |
| COLES N ANTHONY | Director | Nov 02, 2023 | Option Exercise | $3.50 | 38,599 | 135,097 | 41,303 | Nov 06, 2023, 05:12 PM |
| COLES N ANTHONY | Director | Nov 02, 2023 | Sale | $25.19 | 38,599 | 972,239 | 2,704 | Nov 06, 2023, 05:12 PM |
| COLES N ANTHONY | Director | Nov 03, 2023 | Sale | $25.43 | 61,401 | 1,561,458 | 2,704 | Nov 06, 2023, 05:12 PM |
| PATRICK DEVAL L | Director | Nov 01, 2023 | Option Exercise | $12.62 | 30,130 | 380,241 | 33,412 | Nov 03, 2023, 04:15 PM |
| PATRICK DEVAL L | Director | Nov 01, 2023 | Sale | $25.00 | 30,130 | 753,250 | 3,282 | Nov 03, 2023, 04:15 PM |
| Gordon Christopher R | Director | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
| Koppel Adam | Director | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 16, 2023 | Buy | $22.81 | 876,808 | 19,999,990 | 10,794,876 | Oct 17, 2023, 04:53 PM |
| COLES N ANTHONY | Director | Sep 07, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Sep 08, 2023, 04:35 PM |
| COLES N ANTHONY | Director | Sep 07, 2023 | Sale | $24.07 | 50,000 | 1,203,415 | 2,704 | Sep 08, 2023, 04:35 PM |
| Renaud Ronald C JR | President & CEO | Aug 03, 2023 | Buy | $23.96 | 83,857 | 2,008,811 | 83,857 | Aug 07, 2023, 05:13 PM |
| Burgess Paul D. | See Remarks | Aug 04, 2023 | Buy | $22.93 | 21,880 | 501,794 | 21,880 | Aug 07, 2023, 05:11 PM |
| COLES N ANTHONY | Director | Jul 11, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Jul 13, 2023, 05:41 PM |
| COLES N ANTHONY | Director | Jul 11, 2023 | Sale | $30.03 | 50,000 | 1,501,340 | 2,704 | Jul 13, 2023, 05:41 PM |
| DEKKERS MARIJN E | Director | Jun 15, 2023 | Sale | $34.43 | 200,000 | 6,886,000 | 402,326 | Jun 20, 2023, 04:56 PM |
| COLES N ANTHONY | CEO and Chairperson | Jun 01, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Jun 05, 2023, 08:12 PM |
| COLES N ANTHONY | CEO and Chairperson | Jun 01, 2023 | Sale | $32.60 | 50,000 | 1,630,070 | 2,704 | Jun 05, 2023, 08:12 PM |
| Bodenrader Mark | See Remarks | Jun 02, 2023 | Sale | $32.95 | 1,895 | 62,440 | 5,522 | Jun 05, 2023, 08:07 PM |
| COLES N ANTHONY | CEO and Chairperson | May 04, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | May 08, 2023, 04:24 PM |
| COLES N ANTHONY | CEO and Chairperson | May 04, 2023 | Sale | $31.47 | 50,000 | 1,573,434 | 15,136 | May 08, 2023, 04:24 PM |
| COLES N ANTHONY | CEO and Chairperson | Apr 11, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Apr 13, 2023, 04:48 PM |
| COLES N ANTHONY | CEO and Chairperson | Apr 11, 2023 | Sale | $25.06 | 50,000 | 1,253,130 | 2,704 | Apr 13, 2023, 04:48 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 02, 2023 | Option Exercise | $3.50 | 47,000 | 164,500 | 49,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 03, 2023 | Option Exercise | $3.50 | 3,000 | 10,500 | 5,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 03, 2023 | Sale | $27.19 | 3,000 | 81,570 | 2,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 02, 2023 | Sale | $27.11 | 47,000 | 1,274,377 | 2,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Feb 07, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Feb 08, 2023, 08:27 PM |
| COLES N ANTHONY | CEO and Chairperson | Feb 07, 2023 | Sale | $33.13 | 50,000 | 1,656,401 | 10,646 | Feb 08, 2023, 08:27 PM |
| COLES N ANTHONY | CEO and Chairperson | Jan 05, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Jan 06, 2023, 05:04 PM |
| COLES N ANTHONY | CEO and Chairperson | Jan 05, 2023 | Sale | $29.94 | 50,000 | 1,496,871 | 3,204 | Jan 06, 2023, 05:04 PM |
| COLES N ANTHONY | CEO and Chairperson | Dec 09, 2022 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Dec 13, 2022, 04:44 PM |
| COLES N ANTHONY | CEO and Chairperson | Dec 09, 2022 | Sale | $26.67 | 50,000 | 1,333,300 | 7,849 | Dec 13, 2022, 04:44 PM |
| Renger John | Chief Scientific Officer | Nov 01, 2022 | Option Exercise | $7.56 | 25,000 | 189,078 | 27,704 | Nov 03, 2022, 04:28 PM |
| Renger John | Chief Scientific Officer | Nov 01, 2022 | Sale | $30.00 | 25,000 | 750,005 | 2,704 | Nov 03, 2022, 04:28 PM |
| Renger John | Chief Scientific Officer | Oct 04, 2022 | Option Exercise | $7.56 | 25,000 | 189,078 | 27,704 | Oct 06, 2022, 04:59 PM |
| Renger John | Chief Scientific Officer | Oct 04, 2022 | Sale | $30.00 | 25,000 | 750,000 | 2,704 | Oct 06, 2022, 04:59 PM |
| PATRICK DEVAL L | Director | Sep 12, 2022 | Option Exercise | $12.62 | 47,705 | 602,037 | 47,705 | Sep 14, 2022, 05:10 PM |
| PATRICK DEVAL L | Director | Sep 12, 2022 | Sale | $30.78 | 47,705 | 1,468,422 | 0 | Sep 14, 2022, 05:10 PM |
| Ceesay Abraham | President | Sep 08, 2022 | Option Exercise | $13.17 | 19,210 | 252,996 | 19,210 | Sep 12, 2022, 04:24 PM |
| Ceesay Abraham | President | Sep 08, 2022 | Sale | $32.50 | 19,210 | 624,325 | 0 | Sep 12, 2022, 04:24 PM |
| Ceesay Abraham | President | Aug 22, 2022 | Option Exercise | $13.17 | 9,605 | 126,498 | 9,605 | Aug 24, 2022, 04:05 PM |
| Ceesay Abraham | President | Aug 22, 2022 | Sale | $32.50 | 9,605 | 312,163 | 0 | Aug 24, 2022, 04:05 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 16, 2022 | Buy | $35.00 | 1,425,000 | 49,875,000 | 6,511,727 | Aug 18, 2022, 05:10 PM |
| Ceesay Abraham | President | Aug 15, 2022 | Option Exercise | $13.17 | 9,606 | 126,511 | 9,606 | Aug 17, 2022, 04:15 PM |
| Ceesay Abraham | President | Aug 15, 2022 | Sale | $34.12 | 9,606 | 327,757 | 0 | Aug 17, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Aug 10, 2022 | Option Exercise | $6.63 | 55,000 | 364,549 | 57,704 | Aug 12, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Aug 10, 2022 | Sale | $40.50 | 55,000 | 2,227,624 | 21,563 | Aug 12, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Aug 05, 2022 | Option Exercise | $3.50 | 20,000 | 70,000 | 22,704 | Aug 09, 2022, 09:23 PM |
| Renger John | Chief Scientific Officer | Aug 08, 2022 | Option Exercise | $3.50 | 10,000 | 35,000 | 12,704 | Aug 09, 2022, 09:23 PM |
| Renger John | Chief Scientific Officer | Aug 05, 2022 | Sale | $32.50 | 20,000 | 650,000 | 2,704 | Aug 09, 2022, 09:23 PM |
| Renger John | Chief Scientific Officer | Aug 08, 2022 | Sale | $37.75 | 10,000 | 377,500 | 2,704 | Aug 09, 2022, 09:23 PM |
| Akamine Scott | Chief Legal Officer | Aug 08, 2022 | Option Exercise | $13.17 | 10,000 | 131,700 | 10,000 | Aug 09, 2022, 09:18 PM |
| Akamine Scott | Chief Legal Officer | Aug 08, 2022 | Sale | $40.00 | 10,000 | 400,001 | 0 | Aug 09, 2022, 09:18 PM |
| Ceesay Abraham | President | Aug 05, 2022 | Option Exercise | $13.17 | 38,424 | 506,044 | 38,424 | Aug 09, 2022, 08:59 PM |
| Ceesay Abraham | President | Aug 08, 2022 | Option Exercise | $13.17 | 19,211 | 253,009 | 19,211 | Aug 09, 2022, 08:59 PM |
| Ceesay Abraham | President | Aug 05, 2022 | Sale | $32.50 | 38,424 | 1,248,780 | 0 | Aug 09, 2022, 08:59 PM |
| Ceesay Abraham | President | Aug 08, 2022 | Sale | $38.62 | 19,211 | 742,024 | 9,605 | Aug 09, 2022, 08:59 PM |
| Renger John | Chief Scientific Officer | Jul 20, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 27,704 | Jul 22, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Jul 20, 2022 | Sale | $30.00 | 25,000 | 750,000 | 2,704 | Jul 22, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Jul 05, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 27,704 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Jul 06, 2022 | Option Exercise | $3.50 | 1,105 | 3,868 | 3,809 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Jul 05, 2022 | Sale | $30.00 | 25,000 | 750,000 | 2,704 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Jul 06, 2022 | Sale | $32.50 | 1,105 | 35,913 | 2,704 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Apr 13, 2022 | Option Exercise | $3.50 | 45,000 | 157,500 | 46,980 | Apr 15, 2022, 04:19 PM |
| Renger John | Chief Scientific Officer | Apr 13, 2022 | Sale | $34.65 | 45,000 | 1,559,092 | 1,980 | Apr 15, 2022, 04:19 PM |
| Renger John | Chief Scientific Officer | Mar 29, 2022 | Option Exercise | $3.50 | 10,000 | 35,000 | 11,980 | Mar 31, 2022, 04:05 PM |
| Renger John | Chief Scientific Officer | Mar 29, 2022 | Sale | $35.00 | 10,000 | 350,000 | 1,980 | Mar 31, 2022, 04:05 PM |
| Renger John | Chief Scientific Officer | Mar 18, 2022 | Option Exercise | $3.50 | 20,000 | 70,000 | 21,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 16, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 16, 2022 | Sale | $30.00 | 25,000 | 750,005 | 1,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 18, 2022 | Sale | $32.50 | 20,000 | 650,004 | 1,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 09, 2022 | Option Exercise | $3.50 | 30,000 | 105,000 | 31,980 | Mar 11, 2022, 04:08 PM |
| Renger John | Chief Scientific Officer | Mar 09, 2022 | Sale | $33.33 | 30,000 | 1,000,000 | 11,980 | Mar 11, 2022, 04:08 PM |
| Renger John | Chief Scientific Officer | Mar 02, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Mar 04, 2022, 04:12 PM |
| Renger John | Chief Scientific Officer | Mar 02, 2022 | Sale | $30.00 | 25,000 | 750,000 | 1,980 | Mar 04, 2022, 04:12 PM |
| Renger John | Chief Scientific Officer | Feb 09, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Feb 11, 2022, 06:46 PM |
| Renger John | Chief Scientific Officer | Feb 09, 2022 | Sale | $30.00 | 25,000 | 750,000 | 1,980 | Feb 11, 2022, 06:46 PM |
| Renger John | Chief Scientific Officer | Dec 27, 2021 | Option Exercise | $3.50 | 4,127 | 14,445 | 6,107 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 23, 2021 | Option Exercise | $3.50 | 5,873 | 20,556 | 7,853 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 27, 2021 | Sale | $35.00 | 4,127 | 144,445 | 1,980 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 23, 2021 | Sale | $35.00 | 5,873 | 205,582 | 1,980 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 21, 2021 | Option Exercise | $3.50 | 7,300 | 25,550 | 9,280 | Dec 23, 2021, 05:14 PM |
| Renger John | Chief Scientific Officer | Dec 21, 2021 | Sale | $32.50 | 7,300 | 237,250 | 1,980 | Dec 23, 2021, 05:14 PM |
| Renger John | Chief Scientific Officer | Dec 15, 2021 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 17, 2021 | Option Exercise | $3.50 | 7,122 | 24,927 | 9,102 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 16, 2021 | Option Exercise | $3.50 | 5,578 | 19,523 | 7,558 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 15, 2021 | Sale | $30.02 | 25,000 | 750,448 | 1,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 17, 2021 | Sale | $32.50 | 7,122 | 231,465 | 1,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 16, 2021 | Sale | $32.50 | 5,578 | 181,285 | 1,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Nov 10, 2021 | Option Exercise | $3.50 | 55,000 | 192,500 | 55,000 | Nov 15, 2021, 04:18 PM |
| Renger John | Chief Scientific Officer | Nov 10, 2021 | Sale | $39.86 | 55,000 | 2,192,187 | 31,368 | Nov 15, 2021, 04:18 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 26, 2021 | Buy | $30.23 | 68,047 | 2,057,061 | 5,086,727 | Aug 31, 2021, 02:15 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 24, 2021 | Buy | $27.73 | 69,761 | 1,934,472 | 4,957,293 | Aug 25, 2021, 07:14 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 23, 2021 | Buy | $25.78 | 44,437 | 1,145,586 | 4,887,532 | Aug 25, 2021, 07:14 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 25, 2021 | Buy | $28.57 | 61,387 | 1,753,827 | 5,018,680 | Aug 25, 2021, 07:14 PM |
| PERCEPTIVE ADVISORS LLC | Director | Jul 07, 2021 | Buy | $25.00 | 200,000 | 5,000,000 | 4,843,095 | Jul 09, 2021, 06:39 PM |
| Sulzberger Gabrielle | Director | Jun 17, 2021 | Buy | $13.06 | 21,084 | 275,357 | 35,354 | Jun 22, 2021, 06:31 PM |
| MISHAN ORLY | Chief Business Officer | Jan 26, 2021 | Option Exercise | $3.50 | 38,450 | 134,575 | 38,450 | Jan 28, 2021, 07:35 PM |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:54 PM |
| Koppel Adam | Director | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:54 PM |
| Gordon Christopher R | Director | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:51 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 27, 2020 | Buy | $10.00 | 3,000,000 | 30,000,000 | 3,157,295 | Oct 29, 2020, 08:00 PM |
| Koppel Adam | Director | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
| Gordon Christopher R | Director | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
| PFIZER INC | 10% Owner | Oct 27, 2020 | Buy | $10.00 | 1,200,000 | 12,000,000 | 27,349,211 | Oct 29, 2020, 05:44 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 21, 2020 | Buy | $10.09 | 43,195 | 435,838 | 157,295 | Oct 22, 2020, 08:34 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 20, 2020 | Buy | $10.00 | 114,100 | 1,141,000 | 114,100 | Oct 22, 2020, 08:34 PM |
| ARYA Sciences Holdings II | 10% Owner | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:25 PM |
| Stone Adam Leo | Chief Executive Officer | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:25 PM |
| ALTMAN MICHAEL SETH | Chief Financial Officer | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:23 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| PFIZER INC | Former 10% Owner | 08/01/2024 | 1,230,714,495 |
| COLES N ANTHONY | Director | 07/01/2024 | 87,500 |
| COLES N ANTHONY | Director | 07/01/2024 | 1,029,535 |
| COLES N ANTHONY | Director | 06/03/2024 | 175,000 |
| COLES N ANTHONY | Director | 06/03/2024 | 2,030,520 |
| COLES N ANTHONY | Director | 05/10/2024 | 175,000 |
| COLES N ANTHONY | Director | 05/10/2024 | 2,105,125 |
| COLES N ANTHONY | Director | 04/01/2024 | 175,000 |
| COLES N ANTHONY | Director | 04/01/2024 | 2,116,640 |
| COLES N ANTHONY | Director | 03/04/2024 | 175,000 |
| COLES N ANTHONY | Director | 03/04/2024 | 2,050,550 |
| COLES N ANTHONY | Director | 02/29/2024 | 175,000 |
| COLES N ANTHONY | Director | 02/29/2024 | 2,057,890 |
| Renger John | Chief Scientific Officer | 02/07/2024 | 89,777 |
| COLES N ANTHONY | Director | 02/07/2024 | 104,110 |
| Tregoning Kathleen | See Remarks | 12/26/2023 | 31,658 |
| Sanchez Ramiro | Chief Medical Officer | 12/26/2023 | 35,000 |
| Sanchez Ramiro | Chief Medical Officer | 12/26/2023 | 424,700 |
| DiPietro Kenneth | Chief Human Resources Officer | 12/22/2023 | 28,000 |
| DiPietro Kenneth | Chief Human Resources Officer | 12/22/2023 | 331,608 |
| Bodenrader Mark | See Remarks | 12/20/2023 | 326,788 |
| DiPietro Kenneth | Chief Human Resources Officer | 12/20/2023 | 259,144 |
| Akamine Scott | Chief Legal Officer | 12/20/2023 | 292,945 |
| Sanchez Ramiro | Chief Medical Officer | 12/20/2023 | 420,528 |
| ALTSCHULLER Susan | Chief Financial Officer | 12/20/2023 | 571,972 |
| Tregoning Kathleen | See Remarks | 12/20/2023 | 260,469 |
| Sanchez Ramiro | Chief Medical Officer | 12/15/2023 | 74,100 |
| Sanchez Ramiro | Chief Medical Officer | 12/15/2023 | 310,393 |
| Sanchez Ramiro | Chief Medical Officer | 12/07/2023 | 35,000 |
| Sanchez Ramiro | Chief Medical Officer | 12/07/2023 | 413,700 |
| Akamine Scott | Chief Legal Officer | 12/07/2023 | 131,700 |
| Akamine Scott | Chief Legal Officer | 12/05/2023 | 98,775 |
| Akamine Scott | Chief Legal Officer | 12/07/2023 | 413,700 |
| Akamine Scott | Chief Legal Officer | 12/05/2023 | 262,500 |
| COLES N ANTHONY | Director | 11/14/2023 | 79,884 |
| COLES N ANTHONY | Director | 11/14/2023 | 573,455 |
| COLES N ANTHONY | Director | 11/08/2023 | 350 |
| COLES N ANTHONY | Director | 11/07/2023 | 94,766 |
| COLES N ANTHONY | Director | 11/08/2023 | 2,516 |
| COLES N ANTHONY | Director | 11/07/2023 | 677,555 |
| COLES N ANTHONY | Director | 11/03/2023 | 214,904 |
| COLES N ANTHONY | Director | 11/02/2023 | 135,097 |
| COLES N ANTHONY | Director | 11/02/2023 | 972,239 |
| COLES N ANTHONY | Director | 11/03/2023 | 1,561,458 |
| PATRICK DEVAL L | Director | 11/01/2023 | 380,241 |
| PATRICK DEVAL L | Director | 11/01/2023 | 753,250 |
| Gordon Christopher R | Director | 10/16/2023 | 124,999,983 |
| Koppel Adam | Director | 10/16/2023 | 124,999,983 |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | 10/16/2023 | 124,999,983 |
| PERCEPTIVE ADVISORS LLC | Director | 10/16/2023 | 19,999,990 |
| COLES N ANTHONY | Director | 09/07/2023 | 175,000 |
| COLES N ANTHONY | Director | 09/07/2023 | 1,203,415 |
| Renaud Ronald C JR | President & CEO | 08/03/2023 | 2,008,811 |
| Burgess Paul D. | See Remarks | 08/04/2023 | 501,794 |
| COLES N ANTHONY | Director | 07/11/2023 | 175,000 |
| COLES N ANTHONY | Director | 07/11/2023 | 1,501,340 |
| DEKKERS MARIJN E | Director | 06/15/2023 | 6,886,000 |
| COLES N ANTHONY | CEO and Chairperson | 06/01/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 06/01/2023 | 1,630,070 |
| Bodenrader Mark | See Remarks | 06/02/2023 | 62,440 |
| COLES N ANTHONY | CEO and Chairperson | 05/04/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 05/04/2023 | 1,573,434 |
| COLES N ANTHONY | CEO and Chairperson | 04/11/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 04/11/2023 | 1,253,130 |
| COLES N ANTHONY | CEO and Chairperson | 03/02/2023 | 164,500 |
| COLES N ANTHONY | CEO and Chairperson | 03/03/2023 | 10,500 |
| COLES N ANTHONY | CEO and Chairperson | 03/03/2023 | 81,570 |
| COLES N ANTHONY | CEO and Chairperson | 03/02/2023 | 1,274,377 |
| COLES N ANTHONY | CEO and Chairperson | 02/07/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 02/07/2023 | 1,656,401 |
| COLES N ANTHONY | CEO and Chairperson | 01/05/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 01/05/2023 | 1,496,871 |
| COLES N ANTHONY | CEO and Chairperson | 12/09/2022 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 12/09/2022 | 1,333,300 |
| Renger John | Chief Scientific Officer | 11/01/2022 | 189,078 |
| Renger John | Chief Scientific Officer | 11/01/2022 | 750,005 |
| Renger John | Chief Scientific Officer | 10/04/2022 | 189,078 |
| Renger John | Chief Scientific Officer | 10/04/2022 | 750,000 |
| PATRICK DEVAL L | Director | 09/12/2022 | 602,037 |
| PATRICK DEVAL L | Director | 09/12/2022 | 1,468,422 |
| Ceesay Abraham | President | 09/08/2022 | 252,996 |
| Ceesay Abraham | President | 09/08/2022 | 624,325 |
| Ceesay Abraham | President | 08/22/2022 | 126,498 |
| Ceesay Abraham | President | 08/22/2022 | 312,163 |
| PERCEPTIVE ADVISORS LLC | Director | 08/16/2022 | 49,875,000 |
| Ceesay Abraham | President | 08/15/2022 | 126,511 |
| Ceesay Abraham | President | 08/15/2022 | 327,757 |
| Renger John | Chief Scientific Officer | 08/10/2022 | 364,549 |
| Renger John | Chief Scientific Officer | 08/10/2022 | 2,227,624 |
| Renger John | Chief Scientific Officer | 08/05/2022 | 70,000 |
| Renger John | Chief Scientific Officer | 08/08/2022 | 35,000 |
| Renger John | Chief Scientific Officer | 08/05/2022 | 650,000 |
| Renger John | Chief Scientific Officer | 08/08/2022 | 377,500 |
| Akamine Scott | Chief Legal Officer | 08/08/2022 | 131,700 |
| Akamine Scott | Chief Legal Officer | 08/08/2022 | 400,001 |
| Ceesay Abraham | President | 08/05/2022 | 506,044 |
| Ceesay Abraham | President | 08/08/2022 | 253,009 |
| Ceesay Abraham | President | 08/05/2022 | 1,248,780 |
| Ceesay Abraham | President | 08/08/2022 | 742,024 |
| Renger John | Chief Scientific Officer | 07/20/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 07/20/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 07/05/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 07/06/2022 | 3,868 |
| Renger John | Chief Scientific Officer | 07/05/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 07/06/2022 | 35,913 |
| Renger John | Chief Scientific Officer | 04/13/2022 | 157,500 |
| Renger John | Chief Scientific Officer | 04/13/2022 | 1,559,092 |
| Renger John | Chief Scientific Officer | 03/29/2022 | 35,000 |
| Renger John | Chief Scientific Officer | 03/29/2022 | 350,000 |
| Renger John | Chief Scientific Officer | 03/18/2022 | 70,000 |
| Renger John | Chief Scientific Officer | 03/16/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 03/16/2022 | 750,005 |
| Renger John | Chief Scientific Officer | 03/18/2022 | 650,004 |
| Renger John | Chief Scientific Officer | 03/09/2022 | 105,000 |
| Renger John | Chief Scientific Officer | 03/09/2022 | 1,000,000 |
| Renger John | Chief Scientific Officer | 03/02/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 03/02/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 02/09/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 02/09/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 12/27/2021 | 14,445 |
| Renger John | Chief Scientific Officer | 12/23/2021 | 20,556 |
| Renger John | Chief Scientific Officer | 12/27/2021 | 144,445 |
| Renger John | Chief Scientific Officer | 12/23/2021 | 205,582 |
| Renger John | Chief Scientific Officer | 12/21/2021 | 25,550 |
| Renger John | Chief Scientific Officer | 12/21/2021 | 237,250 |
| Renger John | Chief Scientific Officer | 12/15/2021 | 87,500 |
| Renger John | Chief Scientific Officer | 12/17/2021 | 24,927 |
| Renger John | Chief Scientific Officer | 12/16/2021 | 19,523 |
| Renger John | Chief Scientific Officer | 12/15/2021 | 750,448 |
| Renger John | Chief Scientific Officer | 12/17/2021 | 231,465 |
| Renger John | Chief Scientific Officer | 12/16/2021 | 181,285 |
| Renger John | Chief Scientific Officer | 11/10/2021 | 192,500 |
| Renger John | Chief Scientific Officer | 11/10/2021 | 2,192,187 |
| PERCEPTIVE ADVISORS LLC | Director | 08/26/2021 | 2,057,061 |
| PERCEPTIVE ADVISORS LLC | Director | 08/24/2021 | 1,934,472 |
| PERCEPTIVE ADVISORS LLC | Director | 08/23/2021 | 1,145,586 |
| PERCEPTIVE ADVISORS LLC | Director | 08/25/2021 | 1,753,827 |
| PERCEPTIVE ADVISORS LLC | Director | 07/07/2021 | 5,000,000 |
| Sulzberger Gabrielle | Director | 06/17/2021 | 275,357 |
| MISHAN ORLY | Chief Business Officer | 01/26/2021 | 134,575 |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | 11/09/2020 | 3,422,618 |
| Koppel Adam | Director | 11/09/2020 | 3,422,618 |
| Gordon Christopher R | Director | 11/09/2020 | 3,422,618 |
| PERCEPTIVE ADVISORS LLC | Director | 10/27/2020 | 30,000,000 |
| Koppel Adam | Director | 10/27/2020 | 100,000,000 |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | 10/27/2020 | 100,000,000 |
| Gordon Christopher R | Director | 10/27/2020 | 100,000,000 |
| PFIZER INC | 10% Owner | 10/27/2020 | 12,000,000 |
| PERCEPTIVE ADVISORS LLC | Director | 10/21/2020 | 435,838 |
| PERCEPTIVE ADVISORS LLC | Director | 10/20/2020 | 1,141,000 |
| ARYA Sciences Holdings II | 10% Owner | 06/09/2020 | 4,990,000 |
| Stone Adam Leo | Chief Executive Officer | 06/09/2020 | 4,990,000 |
| ALTMAN MICHAEL SETH | Chief Financial Officer | 06/09/2020 | 4,990,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CEREVEL THERAPEUTICS HOLDINGS, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 3,560,931 | 0.0033% | -34.65% | Other |
| PENTWATER CAPITAL MANAGEMENT LP | 1,878,719 | 0.98% | -15.37% | Event Driven |
| SOROS FUND MANAGEMENT LLC | 2,151,641 | 1.58% | 10.9% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,469,670 | 0.00528% | -21.59% | Other |
| BAKER BROS. ADVISORS LP | 683,588 | 0.36% | -57.28% | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 1,190,000 | 0.23% | 11.95% | Event Driven, Value |
| MELQART ASSET MANAGEMENT (UK) LTD | 1,099,229 | 3.72% | 16.4% | Event Driven |
| BALYASNY ASSET MANAGEMENT L.P. | 596,407 | 0.04% | -44.63% | Event Driven |
| MAGNETAR FINANCIAL LLC | 1,014,239 | 0.86% | -0.41% | Event Driven, Other |
| SAND GROVE CAPITAL MANAGEMENT LLP | 919,023 | 10.99% | New | Value |
| P SCHOENFELD ASSET MANAGEMENT LP | 796,440 | 7.87% | 6.7% | Event Driven |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 793,349 | 1.22% | 6.12% | Event Driven |
| WATER ISLAND CAPITAL LLC | 766,933 | 3.33% | -2.78% | Event Driven |
| GABELLI FUNDS LLC | 347,624 | 0.11% | -46.01% | Event Driven, Growth, Activists |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 609,765 | 0.05% | 4.66% | Other |
| TIG ADVISORS, LLC | 588,255 | 1.73% | 2469.25% | Event Driven |
| AQR ARBITRAGE LLC | 502,062 | 0.53% | -12.85% | Event Driven |
| RENAISSANCE TECHNOLOGIES LLC | 361,400 | 0.03% | -19.58% | Other |
| D. E. SHAW & CO., INC. | 44,442 | 0.0017% | -89.47% | Other |
| TWIN SECURITIES, INC. | 416,657 | 13.4% | 311.41% | Event Driven |
| PENTWATER CAPITAL MANAGEMENT LP | 400,000 (Put) | 0.21% | New | Event Driven |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 260,399 | 0.22% | New | Event Driven |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 250,000 (Put) | 0.38% | No change | Event Driven |
| GARDNER LEWIS ASSET MANAGEMENT L P | 192,150 | 2.15% | 57.31% | Event Driven |
| TIG ADVISORS, LLC | 164,000 (Put) | 0.48% | New | Event Driven |
| ALPS ADVISORS INC | 128,068 | 0.04% | Exited | Other |
| TUDOR INVESTMENT CORP ET AL | 126,538 | 0.03% | 203.22% | Event Driven, Other |
| P SCHOENFELD ASSET MANAGEMENT LP | 50,000 (Put) | 0.49% | New | Event Driven |
| ALPINE GLOBAL MANAGEMENT, LLC | 50,000 | 0.36% | New | Event Driven |
| GLAZER CAPITAL, LLC | 40,000 | 0.13% | New | Event Driven |
| BLACKSTONE INC. | 20,651 | 0.00353% | -41.33% | Other |
| AQR CAPITAL MANAGEMENT LLC | 19,816 | 0.00124% | 0.36% | Other |
| GOTHAM ASSET MANAGEMENT, LLC | 8,310 | 0.0044% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR CEREVEL THERAPEUTICS HOLDINGS, INC.
STOCK BUYBACKS FOR CEREVEL THERAPEUTICS HOLDINGS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
2.59%
1Q
09/30/2023
15.31%
2Q
06/30/2023
15.64%
3Q
03/31/2023
15.94%
4Q
12/31/2022
16.10%
5Q
09/30/2022
19.24%
6Q
06/30/2022
22.47%
7Q
03/31/2022
22.72%
8Q
12/31/2021
23.22%
9Q
09/30/2021
26.10%
10Q
06/30/2021
42.46%
11Q
03/31/2021
42.75%
12Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CEREVEL THERAPEUTICS HOLDINGS, INC.
LOADING...